CDSCO tells drugmakers to meet global norms by Jan after cough syrup deaths

India's drug regulator has mandated that all pharmaceutical factories comply with international manufacturing standards by January, following the deaths of over 140 children linked to toxic cough syrups. The Central Drugs Standard Control Organisation emphasized that strict inspections will begin, and non-compliant manufacturers will face severe consequences. While larger firms have met earlier deadlines, smaller manufacturers have expressed concerns that the compliance costs could lead to bankruptcies and increased medicine prices. The government has rejected requests for further extensions, prioritizing safety and quality in drug manufacturing.